Objective: To update the evidence-based Nonhormonal Management of Menopause-Associated Vasomotor Symptoms: 2015 Position Statement of The North American Menopause Society.
GSK and Theravance announced positive data from a Phase II study of the dual acting muscarinic antagonist and beta 2...
Amgen announces the results of a Phase II trial evaluating the safety and efficacy of Brodalumab (formerly AMG 827) in...
Boston Scientific Corporation has completed enrolment in the EVOLVE II randomized, controlled clinical trial. The EVOLVE II trial is designed...
Esperion Therapeutics, has announced positive results from a Phase II clinical trial for ETC-1002. This novel small molecule activator of...
Second Sight Medical announced positive three year results post-implant of its Argus II Retinal Prosthesis System from a multi-center clinical...
Paion AG will conduct a Phase II trial with short acting anaesthic/sedative remimazolam in general anaesthesia in cardiac surgery in...
A study published recently in the New England Journal of Medicine concluded the rate of blood clots relating to HeartMate...
Idenix Pharmaceuticals has reported positive data from both an interim analysis of a Phase II study of its drug candidate...
New results from a Phase II study demonstrated that more than 90% of the patients with Glioblastoma multiforme (GBM) treated...